Live bacteria treatment tested for bowel disease
Disease control
Not yet recruiting
This study aims to confirm if a new treatment called MH002 is effective and safe for people with mild-to-moderate ulcerative colitis (UC) whose symptoms aren't fully controlled by their current medication. MH002 is a 'live biotherapeutic' containing specific bacteria designed to …
Phase: PHASE2 • Sponsor: MRM Health NV • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC